Increased in prevalence of cancer across the globe, surge in global geriatric population, and increase in healthcare expenditure worldwide are expected to propel the growth of the global cancer pain market.
The global cancer pain market size accounted for $5.53 Billion in 2018 and is projected to reach $7.54 billion by 2025, registering a CAGR of 4.5% during the forecast period.
Increased in the prevalence of cancer across the globe, a surge in global geriatric population, and increase in healthcare expenditure worldwide have boosted the growth of the global cancer pain market. However, adverse effects associated with the use of drugs employed in cancer pain management hamper market growth. On the contrary, increase in the number of pipeline drugs and untapped potential in emerging market are expected to create lucrative opportunities in the near future.
Download PDF Sample https://www.alliedmarketresearch.com/request-sample/5123
The global cancer pain market is divided on the basis of type, disease indication, and region. Based on type, the market is segmented into opioids, non-opioids, and nerve blockers. The opioids segment held the largest share in 2018, contributing more than half of the market and is expected to continue its dominance throughout the study period. In addition, the segment is estimated to register the fastest CAGR of 5.0% during the forecast period.
On the basis of disease indication, the market is divided into lung cancer, colorectal cancer, breast cancer, prostate cancer, blood cancer, and others. The lung cancer segment dominated the market, accounting for more than one-fifth of the market. Moreover, the segment is projected to witness the fastest CAGR of 6.1% through 2025.
The global cancer pain market is analyzed across various regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across the Asia-pacific region is estimated to manifest the fastest CAGR of 5.4% during the forecast period. However, the market across North America held the largest share in 2018, contributing more than two-fifths of the market.
The global cancer pain market report provides an in-depth analysis of the major market players such as BioDelivery Sciences International, Inc., Aoxing Pharmaceutical Company, Inc., Grnenthal Pharma GmbH & Co. KG, Daiichi Sankyo Co., Ltd., Insys Therapeutics, Inc., Hisamitsu Pharmaceutical Co., Inc., Orexo AB, Mundipharma International Limited, Teva Pharmaceutical Industries Limited, and Pfizer Inc.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060